{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:12:40Z","timestamp":1755216760509,"version":"3.43.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>Hepatic veno-occlusive disease (VOD) is a critical medical emergency with a high mortality rate of up to 90% if not promptly treated. Defibrotide is the only approved medication for VOD treatment, exhibiting anti-inflammatory, antithrombotic, and anti-ischemic properties. This report presents a case of severe VOD in a patient undergoing acute lymphoblastic leukemia (ALL) treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Case Presentation:<\/jats:title>\n            <jats:p>We describe the successful and rapid treatment of severe VOD in an ALL patient using therapeutic plasma exchange (TPE), intravenous immunoglobulin (IVIG), and methylprednisolone (MPZ). The patient showed significant clinical and laboratory improvement after this combined therapeutic approach.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>This case highlights the effectiveness of TPE, IVIG, and MPZ in the treatment of severe VOD in ALL patients, providing insights into alternative therapeutic strategies in the absence of Defibrotide.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mph.0000000000002886","type":"journal-article","created":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T15:00:09Z","timestamp":1716994809000},"page":"e348-e353","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Veno-Occlusive Disease: A Life-saving Novel Approach With Plasma Exchange, IVIG, and Steroid, Without Defibrotide"],"prefix":"10.1097","volume":"46","author":[{"given":"Banu","family":"Katlan","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Intensive Care Unit"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Funda","family":"Erkasar","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Hematology"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mesut","family":"Topdemir","sequence":"additional","affiliation":[{"name":"of Pediatrics"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gul\u00e7in","family":"G\u00fcnaydin","sequence":"additional","affiliation":[{"name":"Radiology, Mersin Training and Research Hospital, Mersin, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alptug","family":"Ozen","sequence":"additional","affiliation":[{"name":"Radiology, Mersin Training and Research Hospital, Mersin, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2024,5,30]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/S2352-3026(19)30201-7","article-title":"Diagnosis, grading, and treatment recommendations for children, adolescents, and young adults with sinusoidal obstructive syndrome: an international expert position statement","volume":"7","author":"Mahadeo","year":"2020","journal-title":"Lancet Haematol"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/s41409-023-01992-8","article-title":"Diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT)","volume":"58","author":"Mohty","year":"2023","journal-title":"Bone Marrow Transplant"},{"key":"R3-20250804","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3389\/fimmu.2020.00489","article-title":"Diagnosis and treatment of VOD\/SOS after allogeneic hematopoietic stem cell transplantation","volume":"11","author":"Bonifazi","year":"2020","journal-title":"Front Immunol"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1111\/bjh.16557","article-title":"Modified diagnostic criteria, grading classification and newly elucidated pathophysiology of hepatic SOS\/VOD after haematopoietic cell transplantation","volume":"190","author":"Cairo","year":"2020","journal-title":"Br J Haematol"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2217\/ijh-2017-0015","article-title":"Defibrotide for the treatment of hepatic veno-occlusive disease\/sinusoidal obstruction syndrome with multiorgan failure","volume":"6","author":"Richardson","year":"2017","journal-title":"Int J Hematol Oncol"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1177\/1060028017732586","article-title":"Defibrotide: an oligonucleotide for sinusoidal obstruction syndrome","volume":"52","author":"Aziz","year":"2018","journal-title":"Ann Pharmacother"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1177\/1078155215591387","article-title":"Prophylaxis and treatment recommendations for sinusoidal obstruction syndrome in adult and pediatric patients undergoing hematopoietic stem cell transplant: a review of the literature","volume":"22","author":"Hopps","year":"2016","journal-title":"J Oncol Pharm Pract"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1182\/blood-2003-01-0255","article-title":"Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation","volume":"102","author":"Wadleigh","year":"2003","journal-title":"Blood"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.bbmt.2009.08.024","article-title":"Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome","volume":"16","author":"Coppell","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00277-021-04526-8","article-title":"Hepatic sinusoidal obstruction syndrome post-chemotherapy in pediatric and adolescent age: case series of six patients in Qatar","volume":"101","author":"AlSaad","year":"2022","journal-title":"Ann Hematol"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1038\/s41375-021-01203-7","article-title":"Hepatic sinusoidal obstruction syndrome and short-term application of 6-thioguanine in pediatric acute lymphoblastic leukemia","volume":"35","author":"Stanulla","year":"2021","journal-title":"Leukemia"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.3904\/kjim.2021.082","article-title":"Hepatic sinusoidal obstruction syndrome\/veno-occlusive disease after hematopoietic cell transplantation: historical and current considerations in Korea","volume":"36","author":"Yoon","year":"2021","journal-title":"Korean J Intern Med"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.bbmt.2019.11.012","article-title":"Refractory thrombocytopenia is a valid early diagnostic criteria for hepatic veno-occlusive disease in children","volume":"26","author":"Embaby","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.bbmt.2014.09.026","article-title":"Veno-occlusive disease of the liver in the absence of elevation in bilirubin in pediatric patients after hematopoietic stem cell transplantation","volume":"21","author":"Myers","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/s41375-018-0265-z","article-title":"Inotuzumab ozogamicin in pediatric patients with relapsed\/refractory acute lymphoblastic leukemia","volume":"33","author":"Bhojwani","year":"2019","journal-title":"Leukemia"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.bbmt.2006.09.012","article-title":"Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the prevention of hepatic veno-occlusive disease in hematopoietic stem cell transplantation","volume":"13","author":"Tay","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"R17-20250804","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1182\/blood-2001-12-0159","article-title":"Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation","volume":"100","author":"Ruutu","year":"2002","journal-title":"Blood"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/sj.bmt.1703342","article-title":"A randomized trial of heparin plus ursodiol vs. heparin alone to prevent hepatic veno-occlusive disease after hematopoietic stem cell transplantation","volume":"29","author":"Park","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"R19-20250804","first-page":"1026","article-title":"High-dose, continuous r-TPA infusion for treatment of VOD","volume":"18","author":"Graphakos","year":"1996","journal-title":"Bone Marrow Transplant"},{"key":"R20-20250804","doi-asserted-by":"crossref","first-page":"680","DOI":"10.6002\/ect.2021.0475","article-title":"Therapeutic plasma exchange in pediatric patients with sinusoidal obstruction syndrome\/veno-occlusive disease after hematopoietic stem cell transplantation: a single-center experience","volume":"20","author":"Akinci","year":"2022","journal-title":"Exp Clin Transplant"},{"key":"R21-20250804","first-page":"34","article-title":"Complete resolution of transplantation-associated thrombotic microangiopathy and hepatic veno-occlusive disease by defibrotide and plasma exchange","volume":"16","author":"Besisik","year":"2005","journal-title":"Turk J Gastroenterol"},{"key":"R22-20250804","first-page":"313","article-title":"Reversal of severe hepatic veno-occlusive disease by combined plasma exchange and rt-PA treatment","volume":"16","author":"Espigado","year":"1995","journal-title":"Bone Marrow Transplant"},{"key":"R23-20250804","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/hep.510230326","article-title":"Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: the role of glutathione and relevance to hepatic venoocclusive disease","volume":"23","author":"DeLeve","year":"1996","journal-title":"Hepatology"},{"key":"R24-20250804","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.bbmt.2009.01.013","article-title":"The release of soluble factors contributing to endothelial activation and damage after hematopoietic stem cell transplantation is not limited to the allogeneic setting and involves several pathogenic mechanisms","volume":"15","author":"Palomo","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"R25-20250804","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.bbmt.2017.03.008","article-title":"Defibrotide for patients with hepatic veno-occlusive disease\/sinusoidal obstruction syndrome: interim results from a treatment IND study","volume":"23","author":"Richardson","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"R26-20250804","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1007\/s00134-022-06793-z","article-title":"Plasma exchange in the intensive care unit: a narrative review","volume":"48","author":"Bauer","year":"2022","journal-title":"Intensive Care Med"},{"key":"R27-20250804","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40635-023-00510-w","article-title":"Research priorities for therapeutic plasma exchange in critically ill patients","volume":"11","author":"David","year":"2023","journal-title":"Intensive Care Med Exp"},{"key":"R28-20250804","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/intimm\/dxx039","article-title":"IVIG-mediated effector functions in autoimmune and inflammatory diseases","volume":"29","author":"Galeotti","year":"2017","journal-title":"Int Immunol"},{"key":"R29-20250804","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s12098-008-0210-7","article-title":"Pulse steroid therapy","volume":"75","author":"Sinha","year":"2008","journal-title":"Indian J Pediatr"},{"key":"R30-20250804","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.bbmt.2012.11.011","article-title":"High-dose methylprednisolone for veno-occlusive disease of the liver in pediatric hematopoietic stem cell transplantation recipients","volume":"19","author":"Myers","year":"2013","journal-title":"Biol Blood Marrow Transplant"},{"key":"R31-20250804","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.bbmt.2017.09.007","article-title":"Combination of high dose methylprednisolone and defibrotide for veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients","volume":"24","author":"Gloude","year":"2018","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002886","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:06:44Z","timestamp":1754338004000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000002886"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,30]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000002886","relation":{},"ISSN":["1077-4114"],"issn-type":[{"type":"print","value":"1077-4114"}],"subject":[],"published":{"date-parts":[[2024,5,30]]},"assertion":[{"value":"2024-01-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}